Breast cancer 2025

P01 Studying the effectiveness of psychotherapy based on acceptance and commitment on anxiety and depression and quality of parent-child relationship in mothers with breast cancer and their children
Leila Dehghanian, Iran
P02 Primary breast lymphoma: A single centre experience
Jaime Seah, Singapore
P03 Incidence of cancer related fatigue (CRF) in Indian women with breast cancer; an overview of psychosocial issues in breast cancer patients receiving chemotherapy
Vineet Talwar, India

Breast cancer genetics

P04 The efficacy of neoadjuvant chemotherapy for breast cancer in BRCA1 and BRCA2 mutation carriers
Arisa Ata, Japan
P05 Quality of life according to risk-reducing salpingo-oophorectomy in Korean BRCA carriers
Eunyoung Kang, Korea
P06 Clinical outcomes according to BRCA gene status in breast cancer patients. Can the  BRCA gene mutation be used as a prognostic factor for breast cancer?
Jong Eun Lee, Korea
P07 BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
Yan Liu, China
P08 Culturally  cancer risk counseling and education for underserved Latinas
Lina Mayorga, USA
P09 Risk reduction mastectomy in BRCA mutation carriers
Junko Takei, Japan

Breast cancer screening

P10 Borderline lesions diagnosed on breast core biopsy: Frequency of atypia and carcinoma on surgical excision – local clinical experience
Henry Bevis, Australia
P11 Early detection of breast cancer with albumin and hemoglobin adducts of estrogen quinone
Dar-Ren Chen, Chinese Taipei
P12 Effects of breast cancer open biopsy on the status of axillary lymph node metastasis
Yin Yin Chen, Chinese Taipei
P13 Pure mucocele-like lesions of the breast: Is there a role for open biopsy after core needle biopsy?
Kok On Ho, Singapore
P14 Breast cancer treatment delays among young women in a developing country
Monica Rivera Franco, Mexico

Breast imaging

P15 An efficient gradient-distortion method for accurate diagnosis of human organ medical image
Daewon Chung, Korea
P16 Tumor size and proliferative marker geminin rather than Ki67 expression levels were significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers
Yukie Fujimoto, Japan
P17 Computed tomography liver spleen ratio as predictive marker of liver injury among  adult Filipina early breast cancer receiving neoadjuvant therapy from 2010-2016: A  six-year retrospective study
Amabelle Trina Gerona, Philippines
P18 Breast tissue stability of the SAVI SCOUT reflector from implantation to excision: A  post-hoc analysis from a prospective multi-site trial
Jiyon Lee, USA

Breast reconstruction

P19 Mastectomy skin flap perfusion when using PICO® “negative pressure wound dressing” therapy
Henry Bevis, Australia
P20 Lipofilling as bridge to implant-based delayed breast reconstruction in post- mastectomy radiation therapy patient
Jendana Chanyaputhipong, Thailand
P21 Comparison between negative pressure wound therapy on partial mammectomy scar and dry dressing in a patient with high risk factor of bad healing
Clément Dabiri, France
P22 Management of central tumors with the Grisotti technique
Clément Dabiri, France
P23 Breast oncoplastic operations in breast cancer patients with unfavorable prognostic features
Valerijus Ostapenko, Lithuania

Her2 positive breast cancer

P24 The efficacy and tolerability of T-DM1 in Japanese HER2 positive metastatic breast cancer patients
Kei Komatsu, Japan
P25 Significance of Ki67 in predicting response to neoadjuvant chemotherapy in HER2- positive breast cancer patients
Haruna Sakai, Japan
P26 The experiences of the use of T-DM1 for distant metastases in HER2-positive breast cancer
Terumasa Sawada, Japan

Local and locoregional therapy

P27 Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma
Yayoi Adachi, Japan
P28 The characteristics and management of outcomes in older women with breast cancer in New Zealand
Tania Blackmore, New Zealand
P29 Manpower and resource planning for setting up a deep inspiratory breath hold (DIBH) radiation therapy: A prospective study
Sanjoy Chatterjee, India
P30 Comparison of AJCC 8th and 7th edition staging for carcinoma breast: A survival analysis
Kunal Choudhary, India
P31 Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast  cancer
Euitae Kim, Korea
P32 Is supraclavicular lymph node dissection recommended for clinical N3c breast cancer after neoadjuvant chemotherapy?
Joo Heung Kim, Korea
P33 Mastectomy or breast conservation surgery in early breast cancer? Factors affecting patient choice
Luyu Kuo, Australia
P34 Characteristics and treatment for breast cancer for Asian and Pacific women in New Zealand
Chunhuan Lao, New Zealand
P35 Will systemic adjuvant therapy be necessary after concerving breast recurrences?
Misaki Matsuyanagi, Japan
P36 Is reliable to preserve lymphatics of the arm in axilla and reduced occurence of lymphedema in breast cancer patient with axila surgery ?  The anatomical study
David Pavlišta, Czech Republic
P37 Factors influencing reoperation following breast conserving surgery
Andrew Philpott, Australia
P38 Paget’s disease of the breast. A clinicopathologic study
Nikolaos Salemis, Greece
P39 Male breast cancer. Diagnostic evaluation and management.
A clinicopathologic study
Nikolaos Salemis, Greece
P40 Invasive micropapillary carcinoma of the breast. A rare presentation of an agrressive malignancy and review of the literature
Nikolaos Salemis, Greece
P41 Axillary dissection after sentinel lymph node biopsy: Are updated ASCO guidelines universally applicable?
Prafulla Shakya, Nepal
P42 Thirty-six cases that were clinically node positive at diagnosis and underwent sentinel node biopsy after neoadjuvant chemotherapy followed by omitting axillary dissection
Yumiko Taki, Japan
P43 The impact of classification on breast conservation rates for multifocal and multicentric breast cancers
Mona P. Tan, Singapore
P44 Video-assisted breast sugery (VABS) excels in the treatment results and the postoperative aesthetic results
Koji Yamashita, Japan
P45 Pre-operative ultrasound guidance combined with a carbon nanoparticle tracer for sentinel lymph node biopsy in breast cancer patients
Liulu Zhang, China

Molecular assays

P46 The use of oncotype DX to evaluate the significance of HER2 protein expression in hormone-positive breast cancer
Yoko Kanada, Japan
P47 Trail sensitizes cystidine deprivation-mediated cell death in hypoxia
Mi Ri Kim, Korea
P48 Aloe-emodin enhances tamoxifen cytotoxicity by suppressing Ras/ERK and PI3K/mTOR in breast cancer cells
Hung Ting Lin, Chinese Taipei
P49 HIF-1alpha  K674 acetylation by trichostatin a is associated with drug resistance induction under normoxic conditions
Eun Yi Moon, Korea
P50 Predictive value of the 21-gene recurrence score for invasive lobular carcinoma
Mamika Nakamura, Japan
P51 Clinical characteristics of the breast cancer patients treated with chemotherapy by the histoculture drug response assay at a single institution
Sang Eun Nam, Korea
P52 Downregulation of breast carcinoma amplification sequence 1 (BCAS1) overcomes  tamoxifen-resistant in breast cancer cells
In-Chul Park, Korea
P53 The expression of human epididymis protein 4 in breast cancer
Shyr-Ming Sheen-Chen, Chinese Taipei
P54 The current status of 21-gene signature in early breast cancer patients with hormone receptor positive at single institution in Japan
Mitsuo Terada, Japan
P55 Clinical and potential molecular parameters for predicting recurrence of patients diagnosed with breast phyllodes tumors
Ya-Wen Yang, Chinese Taipei

Neoadjuvant therapy

P56 Prognostic effect of sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer
Choi Hee Jun, Korea
P57 Anti-cancer synergy effects for anemarrhena asphodeloides bunge and Coptis chinensis using conditionally reprogrammed breast cancer cell and breast cancer cell lines
Chang-Ho Jeon, Korea
P58 Neuroendocrine breast carcinoma: Can surgery be avoided?
Jacques Marnewick, New Zealand

Triple negative breast cancer

P59 The role of L1 retrotransposons in triple negative breast cancer
Pey-Tsyr Chiou, Australia
P60 Differences in triorganometallics-induced cytotoxicity and modulation of migration in triple-negative breast cancer cell line mda-mb-231
Luba Hunakova, Slovakia
P61 High PD-L1 expression is closely associated with tumor-infiltrating lymphocytes and leads to good clinical outcomes in Chinese triple negative breast cancer patients
Ying Lin, China
P62 Appropriate management for elderly patients with triple negative breast cancer
Ayuha Yoshizawa, Japan